Skip to main navigation Skip to search Skip to main content

Telmisartan, ramipril, or both in patients at high risk for vascular events

  • The ONTARGET Investigators

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1547-1559
Number of pages13
JournalNew England Journal of Medicine
Volume358
Issue number15
DOIs
StatePublished - Apr 10 2008
Externally publishedYes

ASJC Scopus Subject Areas

  • General Medicine

Keywords

  • Benzoates/adverse effects
  • Double-Blind Method
  • Follow-Up Studies
  • Humans
  • Middle Aged
  • Kaplan-Meier Estimate
  • Male
  • Risk
  • Hospitalization
  • Creatinine/blood
  • Angiotensin II Type 1 Receptor Blockers/adverse effects
  • Ramipril/adverse effects
  • Angioedema/chemically induced
  • Telmisartan
  • Diabetes Mellitus/drug therapy
  • Benzimidazoles/adverse effects
  • Cardiovascular Diseases/drug therapy
  • Blood Pressure/drug effects
  • Angiotensin-Converting Enzyme Inhibitors/adverse effects
  • Female
  • Aged
  • Drug Therapy, Combination

Cite this